Retatrutide at the 12 mg dose produces approximately 28.7% body weight loss at 68 weeks, compared to 14.9% with semaglutide 2.4 mg at the same timepoint
Pagali has received the Mayo Clinic CTSA (Mayo Clinic Small grants) through grant number UL1TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)
Regarding receptor-specific interactions, the retatrutideGLP-1R complex displays three salt bridges (D9 P R 7.35b , D15 P R299 ECL2 and K17 P E 1.33b ), with the first two also present in the retatrutideGIPR complex, while the last one is absent in GIPR due to the positively charged R131 1.33b
By February 2025 for semaglutide and March 2025 for tirzepatide, FDA declared both shortages resolved and transitional exemption windows ended
Increases fat metabolism Unlike single receptor therapies, Retatrutide actively increases how your body burns fat
The research was published Monday in The Lancet Diabetes & Endocrinology